Clinical Trials Directory

Trials / Completed

CompletedNCT03499496

Screening for Atherotic Plaques by Ultrasound for Assessing Cardiovascular Risk

Prevalence of Atherosclerotic Carotid and/or Femoral Plaques in Patients Without Known Cardiovascular Disease and at Low-risk for Major Cardiovascular Events (AGLA/GLSA Score) Visiting a Private Primary Healthcare Practice in Switzerland

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Cabinet de Medecine Interne Générale Demetrio Pitarch · Academic / Other
Sex
All
Age
41 Years – 72 Years
Healthy volunteers
Accepted

Summary

Cardiovascular disease is a common diagnosed and treated condition in private practices of primary health care. There is growing evidence that atherosclerotic plaques as predictors for stroke and heart attack are more prevalent than expected based on the clinical score in people with low risk for stroke and heart attack . Diagnosing atherosclerotic plaques can help to decide if a lipid lowering therapy should be prescribed even if the clinical risk score is low or on the other hand if they can be observed even in high lipid levels.

Detailed description

Both common and proximal internal carotid arteries and both common femoral arteries (including bifurcations) were screened by ultrasound in patients who came for a check-up to a primary care practice with no known cardiovascular disease and low risk for stroke and heart attack according to the AGLA/GSLA risk score which is mostly used in Switzerland. All patients agreed and gave written informed consent to be included in this study. Presence of plaques was defined as a focal carotid intima-media thickness \>0.5 cm on ultrasound. Screening was performed by a medical doctor (DP) certified for the procedure using the following ultrasound system: Toshiba Nemio XG, probe 7.5 MhZ.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTultrasound guided detection of atherosclerotic plaquesscreening by ultrasound of atherosclerotic plaques

Timeline

Start date
2016-01-15
Primary completion
2016-08-30
Completion
2016-09-04
First posted
2018-04-17
Last updated
2018-04-17

Source: ClinicalTrials.gov record NCT03499496. Inclusion in this directory is not an endorsement.